-
Sector Analysis
C-Arms Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
C-Arms Market Insights The C-Arms market size was estimated at $1.92 billion in 2023 and is forecast to grow at a CAGR of more than 3% during 2023 and 2033. C-Arm fluoroscopic X-ray systems are used in various diagnostic imaging and minimally invasive surgical procedures. In the operating room (OR), they help visualize procedures for vascular, cardiology, orthopedic, and other therapeutic areas. C-Arms have become increasingly popular due to their wide range of utility. C-Arms Market Outlook 2023-2033 ($ Billion)...
-
Sector Analysis
NewOman Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2029
Oman Defense Market Report Overview The Oman defense budget is $8 billion in 2024. The country’s defense budget will grow at a CAGR of more than 2% during 2025-2029. This can be attributed to the rising arms race in the region to intercept the growing turbulence in neighboring countries such as Syria and Yemen. In addition, the increase in oil prices will facilitate increases in Oman's defense budget. Oman Defense Market Outlook, 2024-2029 ($ Billion) Buy the Full Report for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ARM-210 in Ventricular Tachycardia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ARM-210 in Ventricular Tachycardia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ARM-210 in Ventricular Tachycardia Drug Details: ARM-210 is under development for the...
-
Track & Monitor
Innovation in automotive: Releasable pedal arms
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s Releasable pedal arms segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Thematic Analysis
NewScaling Rearmament – Thematic Intelligence
Reasons to buy the ‘Scaling Rearmament’ thematic intelligence report: Obtain in-depth insights into different rearmament efforts being undertaken by various military organizations and defense companies to understand the market better. Study the emerging trends and how they will influence the scaling rearmament theme and their broader impact on the defense market. Get an overview of the specific drivers of large-scale rearmament today, as well as the challenges that forces and defense sector suppliers face. Explore thematic investment opportunities for armed...
-
Product Insights
NewLikelihood of Approval Analysis for Merkel Cell Carcinoma
Overview How likely is it that the drugs in Merkel Cell Carcinoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Merkel Cell Carcinoma Overview Merkel cell carcinoma is a rare aggressive...
-
Product Insights
NewLikelihood of Approval Analysis for Atherosclerosis
Overview How likely is it that the drugs in Atherosclerosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Atherosclerosis Overview Atherosclerosis (or arteriosclerotic vascular disease) is a condition where the arteries...
-
Product Insights
NewLikelihood of Approval Analysis for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Overview How likely is it that the drugs in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Overview Chronic inflammatory demyelinating...
-
Product Insights
NewLikelihood of Approval Analysis for Prurigo
Overview How likely is it that the drugs in Prurigo will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Prurigo Overview Prurigo nodularis (PN) is a skin disease characterized by pruritic (itchy)...
-
Product Insights
NewLikelihood of Approval Analysis for Myocardial Infarction
Overview How likely is it that the drugs in Myocardial Infarction will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Myocardial Infarction Overview Myocardial infarction is the irreversible necrosis of heart muscle...